针对瘤-瘤微环境的交叉通话
Sunil S Badve1, Yesim Gökmen-Polar1
1Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
Expert opinion on therapeutic targets
|July 3, 2023
概括
向癌细胞及其微环境 (TME) 是克服治疗耐药性的有希望的策略. 共同向瘤-TME相互作用可以改善癌症控制和临床结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症的发展涉及癌细胞及其微环境 (TME) 的复杂的共同进化.
- 传统疗法主要针对癌细胞,经常忽视关键的T-TME相互作用.
- 瘤-TME交叉对话和异质性对治疗耐药性有着显著的贡献.
研究的目的:
- 审查瘤TME系统的组件.
- 探索共同向瘤和TME元素的潜力,以改善癌症治疗方法.
- 讨论在抗癌治疗中针对TME组件的策略.
主要方法:
- 在PubMed和ClinicalTrials.gov的文献综述,截至2023年5月.
- 对T-TME相互作用及其在癌症进展中的作用的分析.
- 在临床前和临床环境中评估共同准方法.
主要成果:
- 在一些模型中,共同准瘤和TME组件在预防瘤进展和转移方面取得了成功.
- 了解组织特异性T-TME相互作用对于治疗反应至关重要.
- 存在各种策略,以准TME组件在抗癌疗法.
结论:
- 对瘤和TME的双重向有望提高癌症控制.
- 考虑组织背景和瘤类型对于优化治疗策略至关重要.
- 对T-TME相互作用的进一步研究可以改善临床结果.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


